We retrospectively enrolled 19 patients that had refractory anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonitis who were unable to achieve disease control on intensive combination immunosuppressive therapy with glucocorticoids and immunosuppressive agents. This evidence concerns the gene IFIH1 and dermatomyositis.